🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is my 32nd birthday. Over the last month, I asked several 90-year-olds what advice they would give to their 32-year-old selves. Here's the life advice everyone needs to hear:

Six years ago I was told to prepare to die. This is the improbable, inspiring, love-filled, hope-filled, true story about the extraordinary campaign that happened next. This is where you come in: please share this trailer with everyone so that we can bring hope to everyone.

The perfect drug name doesn't exi--

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients: Cancer Cell cell.com/cancer-cell/fu…

Hospitali ya Taifa Muhimbili imesema itaendelea kushirikiana na wadau mbalimbali ikiwemo Taasisi ya Novarts Institute of Biomedical Research (NIBR) ya Marekani katika kuwajengea uwezo wataalamu wa MNH na kufanya tafiti ili kukabiliana na ugonjwa wa seli mundu nchini.

Today at our headquarters in Lubowa, we have held a community engagement with the SCD civil society organizations together with a team from Novartis Institutes for BioMedical Research aimed at understanding the in-vivo gene therapy cure for sickle cell disease. #JCRCInnovations

Timely also as Adam Sperling from Dana-Farber is giving an oral presentation this weekend at #ASCO2023 on clinical results in late stage R/R MM with PHE885, a BCMA CAR-T built using the same rapid manufacturing process (ie minimal ex vivo expansion to preserve T cell “stemness”)

Phase 1 trial of fully human, BCMA CAR-T PHE885 manufactured in <2 days on the T-Charge platform, presented by Adam Sperling, MD, PhD, (Adam Sperling) at #ASCO23. Data shows high response rates with no unexpected safety findings in patients with r/r multiple myeloma.

I feel seen 🤦🏻‍♂️

The pace of translating new technology and new knowledge into new, transformative therapies has never been greater. Let’s make sure the therapies reach all the patients who need them. via The New York Times nytimes.com/2023/06/23/mag…

Good morning San Diego! excited to be here for #ASH2023

Really exciting to be at the plenary session of #ASH23 to witness the first disclosure of preclinical data supporting targeted wiz degradation to induce F hemoglobin. Congrats to Pamela Ting for a great presentation!

#wintersports #nataleinItalia #salifornia

Honored to represent my colleagues on this study. Congrats to among others Akshay Sharma MD Jaap J Boelens 🇳🇱🇺🇸 Jay Bradner, M.D. Maria Cancio Seredev

There’s always one.. 😂

Congrats Gaby Hobbs, loved this, very inspiring! ashpublications.org/ashclinicalnew… ASH Clinical News ASH

It’s a McDreamy night at Fenway!

Kamala Harris didn't lose, America did. As a nation, we collectively failed her—and in doing so we failed girls and women, the LGBTQ community, people of color, Muslims, Jewish people, immigrants, the sick, the poor, the elderly, the people of Ukraine, and Gaza, and the planet.